Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.06 USD
Change Today +0.04 / 1.98%
Volume 349.3K
DRRX On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Felix Theeuwes D.Sc., Ph.D.

Co-Founder, Chairman and Chief Scientific Officer,DURECT Corporation
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Felix Theeuwes, D.Sc., Ph.D. co-founded DURECT Corporation in February 1998 and has been its Chairman and Chief Scientific Officer since July 1998. Dr. Theeuwes held various positions at ALZA Corporation from 1970 to June 1999, including President of New Ventures from August 1997 to August 1998, President of ALZA Research and Development from 1995 to August 1997, President of ALZA Technology Institute from 1994 to April 1995 and Chief Scientist from 1982 to June ...

Read Full Background

Corporate Headquarters*

10260 Bubb Road
Cupertino, California 95014

United States

Phone: 408-777-1417
Fax: 408-777-3577

Board Members Memberships*

Co-Founder, Chairman and Chief Scientific Officer


Unknown/Other Education
Stanford University
Katholieke Universiteit Leuven
Bachelor's Degree
Katholieke Universiteit Leuven

Other Affiliations*

Annual Compensation*

Total Annual Compensation$277,452

Stock Options*

All Other Compensation$16,687
Exercisable Options2,269,515
Exercisable Options Value$3,298
Unexercisable Options258,666
Unexercisable Options Value$406
Total Value of Options$3,703
Total Number of Options2,528,181

Total Compensation*

Total Annual Cash Compensation$294,139
Total Short Term Compensation$277,452
Other Long Term Compensation$16,687
Total Calculated Compensation$747,375
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRRX:US $2.06 USD +0.04


Robert B. Jones Chief Executive Officer, President and Director
Acura Pharmaceuticals, Inc.
Nasrat Hakim Chief Executive Officer, President and Director
Elite Pharmaceuticals, Inc.
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
Stephen J. Farr Ph.D.Co-Founder, Chief Executive Officer, President and Director
Zogenix, Inc.
Robert S. Radie Chief Executive Officer, President and Director
Egalet Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DURECT CORPORATION, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at